A detailed history of Two Sigma Investments, LP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 78,382 shares of RPTX stock, worth $271,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,382
Previous 66,753 17.42%
Holding current value
$271,985
Previous $314,000 17.83%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $35,119 - $54,656
11,629 Added 17.42%
78,382 $258,000
Q1 2024

May 15, 2024

BUY
$4.53 - $8.41 $186,984 - $347,139
41,277 Added 162.02%
66,753 $314,000
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $82,032 - $300,362
25,476 New
25,476 $185,000
Q4 2022

Feb 14, 2023

BUY
$12.5 - $18.13 $195,662 - $283,788
15,653 New
15,653 $230,000
Q2 2022

Aug 15, 2022

BUY
$8.45 - $14.84 $282,230 - $495,656
33,400 New
33,400 $467,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $146M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.